and spinal cord injuries. A greater awareness and increased healthcare expenditure is also driving this growth. “Implantable neurostimulation devices are utilised to modulate nerve activity and ...

Abbott (NYSE: ABT) announced today that it launched a next-generation delivery system for its neuromodulation business.

The ARC-IM Lead is designed to be used with the investigational ONWARD ARC-IM neurostimulator (IPG) and is purpose-built for placement along the spinal cord to stimulate the dorsal roots, with ...

Abbott Park, Illinois Friday, April 4, 2025, 15:00 Hrs [IST] ...

"Requiring only a single incision and involving direct visual placement of the neurostimulation device ... stimulation and monitoring with spinal decompression and instrumented fusion.